how much is 10mg of tirzepatide 10 mg vial Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide Flex-Dose 4 mL Injectable
Description
An extension phase (NCT06780449) will assess longer-term outcomes

In short: GLP-1/GIP therapies improve body composition , helping you lose fat while maintaining and often improving your lean-mass ratio and muscle function

Suppression of appetite and reduction in food intake

Activation of those receptors enhances: Glucose-dependent insulin secretion Suppresses glucagon release at inappropriate times Slows gastric emptying Reduces appetite signals in the brain The combined GLP-1 and GIP activity produces more substantial metabolic effects than GLP-1 alone in clinical trials, resulting in better glycemic control and a larger average weight loss

ATTAIN-MAINTAIN showed weight maintenance after switching from tirzepatide

Mounjaro KwikPen 10mg solution for injection in pre-filled pen Patient Information Leaflet (PIL) (emc)
